Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Palo Santo Venture Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 15
Average round size
info
The average size of a deal this fund participated in
$28M
Portfolio companies 13
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.13
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Medical
  • Health Care
  • Pharmaceutical
  • Information Technology

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Palo Santo Venture Fund:
Typical Co-investors
Palo Santo Venture Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Palo Santo Venture Fund:
There are no funds here. If we find new data, we will add it here.

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Psylo

Biotechnology
$8M03 Jun 2024 Sydney, New South Wales, Australia

Reunion Neuroscience

Biotechnology
Pharmaceutical
$103M02 May 2024 Toronto, Ontario, Canada

Journey Clinical

Health Care
Medical
$8M24 Jan 2023 New York, New York, United States

Gilgamesh Pharmaceuticals

Biotechnology
Health Care
Medical
Pharmaceutical
$39M15 Dec 2022 New York, New York, United States

Sensorium Therapeutics

Health Care
Medical
Therapeutics
$30M04 Oct 2022 Boston, Massachusetts, United States

Fluence

E-Learning
Education
Psychology
Training
$1M04 Nov 2021 New York, New York, United States

wavepaths

Information Technology
$4M03 Nov 2021 London, England, United Kingdom

Delix Therapeutics

Biotechnology
$70M27 Sep 2021 Boston, Massachusetts, United States

Journey Clinical

Health Care
Medical
$3M16 Sep 2021 New York, New York, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Palo Santo Venture Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 15
Average round size 28M
Peak activity year 2021
Lead investments 0
Follow on index 0.13
Exits 1
Group Appearance index 0.93

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Psylo

Biotechnology
$8M03 Jun 2024 Sydney, New South Wales, Australia

Reunion Neuroscience

Biotechnology
Pharmaceutical
$103M02 May 2024 Toronto, Ontario, Canada

Journey Clinical

Health Care
Medical
$8M24 Jan 2023 New York, New York, United States

Gilgamesh Pharmaceuticals

Biotechnology
Health Care
Medical
Pharmaceutical
$39M15 Dec 2022 New York, New York, United States

Sensorium Therapeutics

Health Care
Medical
Therapeutics
$30M04 Oct 2022 Boston, Massachusetts, United States

Fluence

E-Learning
Education
Psychology
Training
$1M04 Nov 2021 New York, New York, United States

wavepaths

Information Technology
$4M03 Nov 2021 London, England, United Kingdom

Delix Therapeutics

Biotechnology
$70M27 Sep 2021 Boston, Massachusetts, United States

Journey Clinical

Health Care
Medical
$3M16 Sep 2021 New York, New York, United States
Crunchbase icon

Content report

The following text will be sent to our editors: